Register now if you don’t want to miss out on a national conference hosted by the ABPI and the National Institute for Health Research (NIHR), which will explore how the pharmaceutical industry and the NHS can harness the benefits of big data and its technologies.
The conference – ‘360° of Health Data: Harnessing Big Data for Better Health’ – will take place on Thursday 21 November 2013 at BMA House in London, and will demonstrate how the UK can remain at the forefront of life sciences research and development globally.
A number of high profile speakers are already confirmed including, Professor Dame Sally Davies, Chief Medical Officer and Chief Scientific Adviser to the Department of Health and Earl Howe, Parliamentary Under Secretary of State, Department of Health. Dr Ruth McKernan, Senior Vice President, Pfizer and Chief Scientific Officer, Neusentis will be giving a keynote speech on behalf of industry.
The ABPI will also be launching a new publication at the event – the Big Data Road map – which will set out a four-point plan to direct progress over the next four years. This will look at how the life sciences industry can work in partnership with academics, the NHS and research funders to create awareness, whilst also maximising the UK environment to deliver innovation and benefits for patients.
Commenting on the conference Bina Rawal, the ABPI’s Medical, Innovation and Research Director, said:
"The UK is perfectly positioned to lead the world in integrating data at every single step of the value chain from early discovery to patient care. We are thrilled to be co-hosting this event with the NHIR, which will be a unique opportunity to create awareness of the value that can be derived from big data and highlight how we can embrace new opportunities created by changes to the UK’s research data landscape."
Health Minister Lord Howe said:
"Using data better will bring huge opportunities to develop improved treatments for patients. I am pleased the ABPI and NIHR are taking this valuable opportunity to gather Government, industry, NHS, academia and research professionals to contribute their perspectives and experience to the debate."
The ABPI conference ‘360° of Health Data’ is on 21 November 2013. To register or find out more about the conference, visit: www.abpievents.org.uk. Username: R&DConference, Password: November2013.
ABPI Press OfficeTel: +44 (0) 20 7747 1441 or +44 20 7747 1410 Mobile: +44 (0) 7808 641811 or +44 7850 312064 Email: firstname.lastname@example.org
There will be complimentary delegate passes available for media via the registration website: www.abpievents.org.uk Username: R&DConference, Password: November2013
The ABPI has published a series of blogs in the run-up to the conference:
About the ABPI
The ABPI represents innovative research-based biopharmaceutical companies, large, medium and small, leading an exciting new era of biosciences in the UK.
Our industry, a major contributor to the economy of the UK, brings life-saving and life-enhancing medicines to patients. Our members supply 90 per cent of all medicines used by the NHS, and are researching and developing over two-thirds of the current medicines pipeline, ensuring that the UK remains at the forefront of helping patients prevent and overcome diseases.
The ABPI is recognised by government as the industry body negotiating on behalf of the branded pharmaceutical industry, for statutory consultation requirements including the pricing scheme for medicines in the UK.
About the NIHR
The National Institute for Health Research (NIHR) is funded through the Department of Health to improve the health and wealth of the nation through research. Since its establishment in April 2006, the NIHR has transformed research in the NHS. It has increased the volume of applied health research for the benefit of patients and the public, driven faster translation of basic science discoveries into tangible benefits for patients and the economy and developed and supported the people who conduct and contribute to applied health research.
The NIHR plays a key role in the Government’s strategy for economic growth, attracting investment by the life-sciences industries through its world-class infrastructure for health research. Together, the NIHR people, programmes, centres of excellence, and systems represent the most integrated health research system in the worl: www.nihr.ac.uk/